Get the Stockscreener App
2.88
1.71%
-0.05
After Hours:
2.88
Ac Immune Sa stock is traded at $2.88, with a volume of 333.93K.
It is down -1.71% in the last 24 hours and down -11.93% over the past month.
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
See More
Previous Close:
$2.93
Open:
$2.83
24h Volume:
333.93K
Relative Volume:
0.49
Market Cap:
$289.73M
Revenue:
-
Net Income/Loss:
$-60.14M
P/E Ratio:
-4.0592
EPS:
-0.7095
Net Cash Flow:
$-68.17M
1W Performance:
+13.83%
1M Performance:
-11.93%
6M Performance:
+30.32%
1Y Performance:
+13.39%
1-Day Range:
$2.75
$2.91
1-Week Range:
$2.44
$2.99
52-Week Range:
$1.4299
$4.00
Ac Immune Sa Stock (ACIU) Company Profile
Compare ACIU vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
2.88 | 294.76M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
486.03 | 126.21B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
790.81 | 82.64B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
756.76 | 47.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.07 | 44.15B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
314.36 | 35.08B | 4.98B | 69.60M | 525.67M | 0.5198 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-31-24 | Initiated | BTIG Research | Buy |
| Feb-01-19 | Downgrade | UBS | Buy → Neutral |
| Jan-04-19 | Initiated | UBS | Buy |
| Apr-05-18 | Initiated | H.C. Wainwright | Buy |
| Mar-23-18 | Downgrade | Credit Suisse | Outperform → Neutral |
| Oct-18-16 | Initiated | Credit Suisse | Outperform |
| Oct-18-16 | Initiated | Jefferies | Buy |
| Oct-18-16 | Initiated | Leerink Partners | Outperform |
View All
Ac Immune Sa Stock (ACIU) Latest News
Will AC Immune SA stock hit new highs in YEAR2025 Historical Comparison & Risk Controlled Swing Alerts - baoquankhu1.vn
AC Immune (ACIU) Begins Phase 1 Trial for New Inflammation Treat - GuruFocus
AC Immune begins phase 1 trial of brain-penetrant NLRP3 inhibitor - Investing.com Nigeria
AC Immune Doses First Participant in Phase 1 Trial of NLRP3 Inhibitor ACI-19764 - TipRanks
AC Immune Initiates Phase 1 Clinical Trial of NLRP3 Inhibitor - The Manila Times
ACIU Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Retail Trends: What analysts say about Alphabet Inc stock2025 Volume Leaders & Low Volatility Stock Suggestions - baoquankhu1.vn
Aug EndMonth: Can AC Immune SA deliver consistent EPS growthTrade Volume Report & Entry and Exit Point Strategies - baoquankhu1.vn
J&J Pauses Enrollment In Trial Of AC Immune-Partnered Anti-Tau Immunotherapy - Citeline News & Insights
AC Immune Says Recruitment Temporarily Paused in Ongoing Study for Alzheimer's Disease Treatment - marketscreener.com
Is AC Immune SA stock a buy before product launchesMarket Growth Review & Advanced Swing Trade Entry Alerts - mfd.ru
AC Immune Says Janssen Pauses Enrollment in Alzheimer’s Trial but Confirms Cash Runway to Q3 2027 - TipRanks
AC Immune SA announces voluntary suspension of recruitment for its Phase II clinical trial (code-named Retain) for Alzheimer's disease treatment - Bitget
AC Immune (NASDAQ: ACIU) details Alzheimer’s trial pause and 2027 cash runway - Stock Titan
Sagimet Biosciences (NASDAQ:SGMT) vs. AC Immune (NASDAQ:ACIU) Financial Survey - Defense World
Should I buy AC Immune SA stock nowWeekly Loss Report & Verified Trade Idea Suggestions - mfd.ru
What is AC Immune SA s debt to equity ratioEarnings Trend Report & Risk Controlled Swing Alerts - mfd.ru
What is AC Immune SA’s book value per shareWeekly Investment Report & Free Weekly Chart Analysis and Trade Guides - mfd.ru
Aug Movers: Can AC Immune SA weather a recessionJuly 2025 Institutional & Weekly Top Gainers Trade List - baoquankhu1.vn
Is AC Immune SA undervalued by DCF analysisJuly 2025 Recap & AI Driven Stock Price Forecasts - mfd.ru
What is AC Immune SA s revenue forecastJuly 2025 Decliners & Target Return Focused Stock Picks - mfd.ru
Bank Watch: Does AC Immune SA outperform in volatile marketsMarket Performance Summary & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
Earnings Beat: Should I trade or invest in CVLGJuly 2025 Market Mood & Low Volatility Stock Suggestions - baoquankhu1.vn
Aug Analyst Calls: Can AC Immune SA weather a recession2025 Market Sentiment & Target Return Focused Stock Picks - baoquankhu1.vn
AC Immune (NASDAQ:ACIU) Lowered to Sell Rating by Wall Street Zen - MarketBeat
Can AC Immune SA weather a recession2025 Valuation Update & Weekly Watchlist for Consistent Profits - mfd.ru
Does AC Immune SA outperform in volatile markets2025 Valuation Update & Weekly High Conviction Ideas - mfd.ru
Will AC Immune SA outperform its industry peersQuarterly Trade Review & Reliable Breakout Stock Forecasts - mfd.ru
Performance Recap: Is Stagwell Inc stock forming a cup and handleGDP Growth & Low Risk High Win Rate Picks - baoquankhu1.vn
Dip Buying: Should I buy AC Immune SA stock nowJuly 2025 Opening Moves & Fast Gain Swing Alerts - baoquankhu1.vn
Will AC Immune SA outperform the market in YEAR2025 Key Highlights & High Win Rate Trade Alerts - Mfd.ru
AC Immune (NASDAQ:ACIU) Stock Price Down 5.4%Time to Sell? - MarketBeat
Profit Recap: Will AC Immune SA outperform its industry peersIPO Watch & Growth Focused Stock Reports - baoquankhu1.vn
Aug Outlook: Will AC Immune SA outperform its industry peersStock Surge & Real-Time Volume Analysis - baoquankhu1.vn
Fed Meeting: Will AC Immune SA outperform its industry peers2025 Market Sentiment & Free Accurate Trade Setup Notifications - baoquankhu1.vn
Risk Off: Why AC Immune SA stock attracts global investors2025 Bull vs Bear & Verified Chart Pattern Trade Signals - Bộ Nội Vụ
Top Penny Stocks To Watch In January 2026 - Yahoo Finance
Trading Recap: Can AC Immune SA stock deliver surprise earnings beatEarnings Overview Report & AI Based Buy/Sell Signal Reports - Bộ Nội Vụ
What insider purchases suggest about AC Immune SA (IMR) stockJuly 2025 Breakouts & Growth Focused Stock Reports - Улправда
What valuation ratios show for AC Immune SA (IMR) stockJuly 2025 Final Week & Weekly High Potential Alerts - Улправда
How AC Immune SA stock benefits from tech adoption2025 Price Targets & Long Hold Capital Preservation Plans - Улправда
How AC Immune SA stock performs after earningsNew Guidance & Expert-Curated Trade Recommendations - ulpravda.ru
Can AC Immune SA stock beat market expectations this quarterMarket Growth Summary & Fast Entry Momentum Trade Alerts - Улправда
Will AC Immune SA stock split again soon2025 EndofYear Setup & Short-Term Trading Alerts - ulpravda.ru
Risk Check: What hedge fund activity signals for AC Immune SA stock2025 Year in Review & Verified Technical Signals - Улправда
AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results - MSN
Retail investors are AC Immune SA's (NASDAQ:ACIU) biggest owners and were rewarded after market cap rose by US$53m last week - Yahoo Finance
Why is AC Immune stock up over 23% today? - MSN
Short Interest in AC Immune (NASDAQ:ACIU) Grows By 94.4% - MarketBeat
Ac Immune Sa Stock (ACIU) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.90%
2.73%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):